Three Questions Every Medicare Advantage Executive Should Be Asking Right Now

The Medicare Advantage Stars program may be entering a new era — one where methodology decisions are increasingly challenged not only through policy channels, but in court. The Clover Health and Elevance Health cases raise important questions for Medicare Advantage executives and quality leaders. But this episode is not about predicting how the courts will rule. Instead, Peter Saah examines three questions every Medicare Advantage executive should be asking right now: 1. Are we entering a new era of Medicare Advantage governance? 2. Should quality leaders be paying more attention to policy than they did five years ago? 3. What should organizations do while the courts decide? The bigger issue is not one lawsuit or one Star Rating methodology. It is how Medicare Advantage organizations should operate when quality performance, reimbursement, regulation, methodology, and litigation increasingly intersect. For quality leaders, the lesson is clear: execution still matters — but understanding the rules shaping execution matters too.